Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand
Q. Sue Huang(New Zealand Institute for Public Health and Forensic Science), Tim Wood(New Zealand Institute for Public Health and Forensic Science), Lauren Jelley(New Zealand Institute for Public Health and Forensic Science), Tineke Jennings(Hutt Hospital), Sarah Jefferies(New Zealand Institute for Public Health and Forensic Science), Karen Daniells(New Zealand Institute for Public Health and Forensic Science), Annette Nesdale(Hutt Hospital), Tony Dowell(University of Otago), Nikki Turner(University of Auckland), Priscilla Campbell‐Stokes(Hutt Hospital), Michelle Balm(Capital and Coast District Health Board), Hazel Dobinson(Capital and Coast District Health Board), Cameron Grant(University of Auckland), Shelley James(Capital and Coast District Health Board), Nayyereh Aminisani(New Zealand Institute for Public Health and Forensic Science), Jacqui Ralston(New Zealand Institute for Public Health and Forensic Science), Wendy Gunn(New Zealand Institute for Public Health and Forensic Science), Judy Bocacao(New Zealand Institute for Public Health and Forensic Science), J Danielewicz(New Zealand Institute for Public Health and Forensic Science), Tessa Moncrieff(New Zealand Institute for Public Health and Forensic Science), Andrea McNeill(New Zealand Institute for Public Health and Forensic Science), Liza Lopez(New Zealand Institute for Public Health and Forensic Science), Ben Waite(New Zealand Institute for Public Health and Forensic Science), Tomasz Kiedrzynski(Ministry of Health), Hannah Schrader(New Zealand Institute for Public Health and Forensic Science), Rebekah Gray(New Zealand Institute for Public Health and Forensic Science), Kayla Cook(New Zealand Institute for Public Health and Forensic Science), Danielle Currin(New Zealand Institute for Public Health and Forensic Science), Chaune Engelbrecht(Hutt Hospital), Whitney Tapurau(Hutt Hospital), Leigh Emmerton(Hutt Hospital), Maxine Martin(Hutt Hospital), Michael G. Baker(University of Otago), Susan Taylor(Counties Manukau District Health Board), Adrian Trenholme(Counties Manukau District Health Board), Conroy Wong(Counties Manukau District Health Board), Shirley Lawrence(Counties Manukau District Health Board), Colin McArthur(Auckland District Health Board), Alicia Stanley(Auckland District Health Board), Sally Roberts(Auckland District Health Board), Fahimeh Rahnama(Auckland District Health Board), Jenny Bennett(Waikato District Health Board), Chris Mansell(Waikato District Health Board), Meik Dilcher(Canterbury District Health Board), Anja Werno(Canterbury District Health Board), Jennifer Grant(Southern District Health Board), Antje van der Linden(Southern District Health Board), Ben Youngblood(St. Jude Children's Research Hospital), Paul G. Thomas(St. Jude Children's Research Hospital), Richard J. Webby(St. Jude Children's Research Hospital)
Cited by 476Open Access
Abstract
Stringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are not currently recommended for pandemic influenza control. New Zealand used these NPIs to eliminate coronavirus disease 2019 during its first wave. Using multiple surveillance systems, we observed a parallel and unprecedented reduction of influenza and other respiratory viral infections in 2020. This finding supports the use of these NPIs for controlling pandemic influenza and other severe respiratory viral threats.
Related Papers
No related papers found
Powered by citation graph analysis